This image is not available for purchase in your country.

Abiraterone acetate cancer drug

Abiraterone acetate cancer drug

C042/0033

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions:

Editorial use only.

Caption

Abiraterone acetate cancer drug. Daily dose blister pack of 500mg tablets of the prostate cancer drug abiraterone acetate, marketed under the name Zytiga. The prostate is a gland beneath the bladder in men which produces a fluid that forms part of the semen. Elevated blood levels of testosterone may increase the risk of prostate cancer. Abiraterone blocks the production of testosterone by inhibiting an enzyme involved in its formation. This leads to the death of the cancerous cells.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}